Movement Alert|Viavi Solutions Falls 5.05% in Regular Trading, Multiple Executives and Directors Engaged in Concentrated Selling

Market Focus
Sep 28

On September 28, Viavi Solutions fell 5.05% in regular trading, trading at $38.625 per share, with turnover of approximately $53.61 million. The decline was primarily driven by a wave of concentrated insider selling, as the company simultaneously filed a Form 144 securities sale report.

According to recent disclosures, 18 insider transactions were reported on September 23. Director Oleg Khaykin sold 294,900 shares at $36.40, totaling approximately $10.74 million. Several senior executives also sold shares on the same date, including Ilan Daskal (69,400 shares for $2.52 million), Luke Scrivanich (37,200 shares for $1.35 million), Paul McNab (35,400 shares for $1.29 million), and Gary Staley (31,700 shares for $1.15 million). The stock had rallied following a strong fiscal Q4 earnings beat in August, where adjusted EPS of $0.34 surpassed the $0.30 estimate and revenue of $443.1 million exceeded the $432.6 million consensus. The concentrated insider selling intensified short-term profit-taking pressure.

Within the Communication Equipment sector, broad weakness was evident. Applied Optoelectronics fell 7.4%, Lumentum dropped 6.16%, Nokia declined 4.02%, Arista Networks lost 1.11%, and Cisco slipped 0.39%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10